Verastem, Inc. financial data

Symbol
VSTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
117 Kendrick Street, Suite 500, Needham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 % -38.7%
Debt-to-equity 275 % +185%
Return On Equity -333 % -187%
Return On Assets -74 % -40.6%
Operating Margin -1.76K % -3916%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.5M shares +76.1%
Common Stock, Shares, Outstanding 40.3M shares +59.4%
Entity Public Float 187M USD
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 40.3M shares +50.3%
Weighted Average Number of Shares Outstanding, Diluted 40.3M shares +50.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10M USD
Revenue from Contract with Customer, Excluding Assessed Tax 10M USD
Research and Development Expense 83M USD +67.4%
Costs and Expenses 125M USD +60.1%
Operating Income (Loss) -115M USD -47.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -93.5M USD -21.7%
Earnings Per Share, Basic -3.07 USD/shares +39%
Earnings Per Share, Diluted -0.6 USD/shares +20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 113M USD +19.1%
Cash, Cash Equivalents, and Short-term Investments 113M USD -31.7%
Assets, Current 121M USD -30.8%
Property, Plant and Equipment, Net 39K USD +11.4%
Operating Lease, Right-of-Use Asset 625K USD -53.2%
Other Assets, Noncurrent 5.05M USD +8921%
Assets 126M USD -28.3%
Accounts Payable, Current 4.44M USD -13.3%
Employee-related Liabilities, Current 4.63M USD +27.6%
Accrued Liabilities, Current 22.2M USD +35.8%
Liabilities, Current 37.4M USD +57%
Operating Lease, Liability, Noncurrent 270K USD -78.4%
Other Liabilities, Noncurrent 51K USD
Liabilities 94.2M USD +31.1%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 21.2M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -4K USD -167%
Retained Earnings (Accumulated Deficit) -891M USD -11.7%
Stockholders' Equity Attributable to Parent 11.1M USD -86.7%
Liabilities and Equity 126M USD -28.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.3M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 846K USD -98.1%
Net Cash Provided by (Used in) Investing Activities 31M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 40.3M shares +59.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.52M USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 113M USD +17.2%
Deferred Tax Assets, Valuation Allowance 152M USD +13.8%
Deferred Tax Assets, Gross 153M USD +13.6%
Operating Lease, Liability 780K USD -53.6%
Depreciation 6K USD -80%
Payments to Acquire Property, Plant, and Equipment 21K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -93.5M USD -21.9%
Lessee, Operating Lease, Liability, to be Paid 819K USD -56.8%
Property, Plant and Equipment, Gross 1.63M USD +0.43%
Operating Lease, Liability, Current 780K USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.08M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 546K USD +104%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39K USD -81.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.08M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 110M USD +6.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 546K USD 0%
Operating Lease, Payments 1.08M USD +2.09%
Preferred Stock, Shares Outstanding 1.2M shares +20%
Interest Expense 1.13M USD -72.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares